University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Nutrition and Health Sciences -- Faculty
Publications

Nutrition and Health Sciences, Department of

2-18-2022

Tissue losses and metabolic adaptations both contribute to the
reduction in resting metabolic rate following weight loss
Alexandra Martin
Darius Fox
Chaise A. Murphy
Hande Hofmann
Karsten Koehler

Follow this and additional works at: https://digitalcommons.unl.edu/nutritionfacpub
Part of the Human and Clinical Nutrition Commons, Molecular, Genetic, and Biochemical Nutrition
Commons, and the Other Nutrition Commons
This Article is brought to you for free and open access by the Nutrition and Health Sciences, Department of at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Nutrition and Health
Sciences -- Faculty Publications by an authorized administrator of DigitalCommons@University of Nebraska Lincoln.

International Journal of Obesity

www.nature.com/ijo

ARTICLE

OPEN

Tissue losses and metabolic adaptations both contribute to the
reduction in resting metabolic rate following weight loss
Alexandra Martin

1

, Darius Fox2, Chaise A. Murphy

1

, Hande Hofmann1 and Karsten Koehler

1✉

1234567890();,:

© The Author(s) 2022

OBJECTIVE: To characterize the contributions of the loss of energy-expending tissues and metabolic adaptations to the reduction
in resting metabolic rate (RMR) following weight loss.
METHODS: A secondary analysis was conducted on data from the Comprehensive Assessment of Long-term Effects of Reducing Intake
of Energy study. Changes in RMR, body composition, and metabolic hormones were examined over 12 months of calorie restriction
in 109 individuals. The contribution of tissue losses to the decline in RMR was determined by weighing changes in the size of
energy-expending tissues and organs (skeletal muscle, adipose tissue, bone, brain, inner organs, residual mass) assessed by dualenergy X-ray absorptiometry with their tissue-speciﬁc metabolic rates. Metabolic adaptations were quantiﬁed as the remaining
reduction in RMR.
RESULTS: RMR was reduced by 101 ± 12 kcal/d as participants lost 7.3 ± 0.2 kg (both p < 0.001). On average, 60% of the total
reduction in RMR were explained by energy-expending tissues losses, while 40% were attributed to metabolic adaptations. The loss
of skeletal muscle mass (1.0 ± 0.7 kg) was not signiﬁcantly related to RMR changes (r = 0.14, p = 0.16), whereas adipose tissue losses
(7.2 ± 3.0 kg) were positively associated with the reduction in RMR (r = 0.42, p < 0.001) and metabolic adaptations (r = 0.31,
p < 0.001). Metabolic adaptations were correlated with declines in leptin (r = 0.27, p < 0.01), triiodothyronine (r = 0.19, p < 0.05), and
insulin (r = 0.25, p < 0.05).
CONCLUSIONS: During weight loss, tissue loss and metabolic adaptations both contribute to the reduction in RMR, albeit variably.
Contrary to popularly belief, it is not skeletal muscle, but rather adipose tissue losses that seem to drive RMR reductions following
weight loss. Future research should target personalized strategies addressing the predominant cause of RMR reduction for weight
maintenance.
International Journal of Obesity (2022) 46:1168–1175; https://doi.org/10.1038/s41366-022-01090-7

INTRODUCTION
Worldwide obesity has tripled in the last decades, with more than
1.9 billion and 650 million adults considered overweight and
obese, respectively [1]. With even modest weight reductions
eliciting health improvements [2, 3], weight loss via the induction
of a negative energy balance is encouraged for obesity treatment.
Calorie restriction is the most common method for weight loss [4],
and while initially efﬁcacious, prolonged calorie restriction results
in attenuated weight loss [5]. This weight loss attenuation occurs
because of reductions in total daily energy expenditure (TDEE)
that oppose the initial energy deﬁcit [6]. These reductions in TDEE
result in a return to energy balance at a lower level, which
increases the likelihood of an energy surplus once weight loss
efforts have stopped and predisposes individuals to future weight
regain [7].
Although reductions secondary to weight loss have been
reported for most components of TDEE [8], reductions in resting
metabolic rate (RMR) have manifested most consistently [9, 10].
RMR is deﬁned as the energy expended at rest for physiological
functionality and comprises ~60–70% of TDEE in the normal
population [11, 12], representing the largest contributor to TDEE.

Thus, its preservation during weight loss has been targeted as a
potential strategy to prevent the compensatory reductions in
TDEE and subsequent weight regain [13].
It has been traditionally assumed that RMR preservation is
enhanced when fat-free mass (FFM) is maintained during weight
loss as FFM is considered the primary determinant of RMR [14].
Further, FFM losses can account for up to 50% of total weight loss
[15] and thus may at least partially explain the variability observed
in RMR following weight loss. However, FFM is a heterogeneous
tissue [16], and the extent of the RMR reduction due to FFM loss is
largely driven by the size and metabolic activity of the speciﬁc
tissues that are lost. The brain and other vital organs consume
more energy than resting skeletal muscle and bone when
expressed relative to their size [16], yet FFM losses during weight
loss are typically limited to skeletal muscle while the vital organs
are preserved [17]. Thus, failure to account for the speciﬁc organ
composition of FFM loss may result in misestimating RMR
reductions due to tissue losses. Further, the contribution of
reductions in other tissues outside of FFM secondary to weight
loss should be accounted for as well [18]. Although fat mass, or
more speciﬁcally adipose tissue, is considered to be relatively inert

1
Department of Sport and Health Sciences, Technical University Munich, Munich, Germany. 2Department of Nutrition and Health Sciences, University of Nebraska-Lincoln,
Lincoln, NE, USA. ✉email: karsten.koehler@tum.de

Received: 8 July 2021 Revised: 29 January 2022 Accepted: 2 February 2022
Published online: 18 February 2022

A. Martin et al.

1169
when compared to other tissues and organs [16], it is typically lost
in much greater quantities [15] and may still meaningfully
contribute to RMR reductions.
Yet, even when the contributions of organs and tissues are
accounted for, RMR continues to decline beyond what would be
expected based on the loss of energy-expending tissues. Müller
et al. reported that only about one-third of the RMR reduction
following 3 weeks of calorie-restricted weight loss was accounted
for by metabolically active tissue, leaving two-thirds of RMR
changes unexplained [19]. This unexplained portion is understood
as a reduction in the metabolic activity of the existing remaining
tissues [20], as evident by the close relationship between adaptive
reductions in RMR and changes in key hormones involved in
energy sensing and metabolism, such as leptin and thyroid
hormones [20–23]. These metabolic adaptations represent the
second important contributor to the reduction in RMR following
weight loss and have been observed in prospective studies
involving calorie restriction [8, 19] as well as in cross-sectional
observations in populations with prolonged exposures to chronic
energy deﬁciency [22, 24].
While both of these distinct phenomena—the loss of energyexpending tissues and the reduction in the metabolic activity of
the remaining tissues—contribute to RMR reduction, it is unclear
whether each contributor occurs independently or whether the
magnitude of different tissue losses impacts the extent of RMR
reductions and metabolic adaptations. The purpose of the present
analysis was to quantify the unique contribution of these two
components to RMR reduction during prolonged weight loss in
healthy normal weight and overweight individuals and their
relationship with each other. To address this objective, we
retrospectively analyzed data from the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE)
[25], a large-scale, randomized-controlled trial. The previously
reported variability in changes in body composition and RMR [26]
enabled us to examine the inter-individual variability in the
contribution of tissue losses and metabolic adaptations to RMR
reduction following weight loss.
METHODS
Study design
The present investigation is a secondary analysis of data from CALERIE
[25], a randomized clinical trial in humans that involved a 25% reduction
in energy intake over the course of a 2-year period. CALERIE was chosen
because it examined long-term weight loss in a free-living study and the
design enabled examination of variability in the causes of RMR
reductions secondary to weight loss, as well as changes in body
composition and hormonal concentrations. All participants signed an
informed consent before study participation. Institutional review boards
at Pennington Biomedical Research Center, Washington University
Medical Center, and Tufts University oversaw the study and the Duke
Clinical Research Institute served as the coordinating center [25]. Despite
a common goal of 25% calorie restriction, there was no mandatory diet
composition imposed nor speciﬁc physical activity required. Dietitians,
physicians, and psychologists gave participants individual counseling
sessions and an interactive database to support and monitor adherence
to calorie restriction prescriptions. Detailed procedures can be found
elsewhere [25, 27]. The study was registered at clinicaltrials.gov as
NCT00427193.

Data extraction
Data were obtained via download of the publicly available dataset [28].
Data from baseline, 6 months, and 12 months were chosen for this analysis
for several reasons. First, metabolic adaptations are more likely to occur
during early weight loss [29, 30]. Second, maximal weight loss in the trial
was achieved at month 12, with no signiﬁcant deviations at later time
points [31]. Third, hormonal data, which was needed to conﬁrm the
presence of metabolic adaptations, was measured only at baseline and
month 12. Finally, later time points at 18 and 24 months had higher
attrition.
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Participants
Potential participants were screened for previous eating disorders,
signiﬁcant health problems, recent substantial weight loss and/or
participation in CALERIE Phase 1, and use of medication except oral
contraceptives. Following initial inclusion, 220 male and female participants 20–50 years of age with a body mass index (BMI) from 22 to 27.9
kg/m2 were randomly assigned 2:1 to 25% caloric restriction (n = 145) or
control group (n = 75). For the purpose of our analysis, participants in the
non-restricted control groups were excluded as only minimal weight loss
was expected. Further, data from participants without complete baseline
or 12-month measurements were excluded.

Assessments
Data used for the present analysis included assessments of body weight,
body composition, RMR, and metabolic hormone concentrations. Body
weight was assessed every 3 months during a clinical visit using an electric
scale (Scale Tronix 5200; Welch Allyn). Body composition was measured
using dual-energy x-ray absorptiometry (DXA) via a standardized protocol
using a 4500 A, Delphi W, or Discovery A scanner (all Hologic, Waltham,
MA) at baseline and months 6 and 12. RMR was measured using indirect
calorimetry (Vista-MX metabolic cart; Vacumed, Ventura, CA) at baseline
and months 6 and 12. Metabolic hormones, including insulin, leptin,
triiodothyronine (T3), and insulin-like growth factor 1 (IGF-1), were
assessed from venous blood samples at baseline and month 12.

Calculations
The extent of changes in RMR attributable to the losses of energyexpending tissues and organs was calculated based on the contribution of
the primary organs and tissues contributing to whole-body RMR [16, 32].
Organs and tissues used for this calculation included skeletal muscle,
adipose tissue, bone, brain, and inner organs (heart, liver, kidneys).
Residual mass was obtained by subtracting each of the organ and tissue
masses from total mass. The size of these organs and tissues were
determined as previously reported [22, 33]. Skeletal muscle, adipose tissue,
bone mass, and brain mass, were assessed from DXA-derived values of
lean tissue in the extremities, fat mass, bone mineral content, and skull
area, respectively [22, 34]. Internal organs weights were calculated from
lean body mass in the trunk [33] (Supplementary Table 1). Metabolic rates
for all organ and tissues were calculated by multiplying the size of each
organ/tissue with their speciﬁc metabolic rate [16]. Predicted RMR was
calculated as the sum of the metabolic rates of all eight components. This
method has previously been used to quantify adaptive reductions in RMR
in various weight loss settings [32, 35] as well as in chronically energydeﬁcient populations such as anorexia nervosa patients [24] and
amenorrheic female athletes [22]. The extent of the metabolic adaptations
was subsequently calculated as the difference between changes in
measured RMR by indirect calorimetry and changes in predicted RMR [32].

Statistical analyses
Statistical analyses were performed with R (version 4.0.3, The R Foundation
for Statistical Computing). If not labeled otherwise, all data are presented
as mean ± standard error of the mean. Changes in outcomes between
baseline and months 6 and 12 were assessed using pairwise, paired T-tests
using the Holm–Bonferroni method.
To determine how reductions in RMR and metabolic adaptations were
related to skeletal muscle and adipose tissue losses, linear regression
analyses were conducted between outcomes and changes in measured
RMR, changes in RMR due to tissue losses, and metabolic adaptations.
Associations between metabolic adaptations and measured RMR with
changes in adipose tissue and skeletal muscle mass were further assessed
using Pearson’s correlation coefﬁcient.
To visualize differences between individuals who lost the most and least
of the speciﬁc tissues, participants were grouped into quartiles based on
their individual changes in skeletal muscle and adipose tissue, respectively,
with the lowest (Q1) and highest (Q4) quartiles referring to the participants
with the greatest losses and the smallest losses and/or gains in a speciﬁc
tissue, respectively. Differences in RMR and metabolic adaptations
between quartiles were assessed using generalized linear model analyses
adjusted for confounders (age, sex, body weight, height, initial BMI, body
fat percentage), using Q1 as reference quartiles.
The association between metabolic adaptations and hormonal changes
was assessed using Pearson’s correlation coefﬁcient. Statistical signiﬁcance
was considered with a probability of error <5% (p < 0.05).
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Table 1.

Baseline characteristics of the 109 participants included in the analysis.
All participants (n = 109)

Age (yr)

Male participants (n = 32)

36.4 ± 7.3

41.0 ± 6.6

71 ± 8.5

67.5 ± 6.2

79.6 ± 7.0

Body Weight (kg)
Height (cm)

Female participants (n = 77)

37.8 ± 7.4
168.2 ± 7.8

165.3 ± 6.7

175.2 ± 5.4

Body Mass Index (kg/m2)

25.0 ± 1.7

24.7 ± 1.6

25.9 ± 1.5

Body Fat (%)

33.0 ± 5.9

35.9 ± 4.2

26.0 ± 2.7

Fig. 1 Changes in body weight, skeletal muscle, adipose tissue, and resting metabolic rate over the course of 12 months of calorierestricted weight loss. Left: Changes in body weight (closed symbols), skeletal muscle (open symbols), and adipose tissue (gray symbols) over
the course of the ﬁrst 12 months of calorie-restricted weight loss. Right: Changes in measured (black bars) and predicted (white bars) resting
metabolic rate over the course of the ﬁrst 12 months of calorie-restricted weight loss.) Data points with different letters are signiﬁcantly
different from one another (p < 0.001).

Table 2.

Changes in the size of tissues and organs contributing to resting metabolic rate.
Baseline

Month 6

Month 12

Mass (kg)

Mass (kg)

Change

Mass (kg)

Change

Skeletal muscle

23.2 ± 5.2

22.2 ± 4.9

−1.0 ± 0.7***

22.2 ± 5.0

−1.0 ± 0.8***

Adipose tissue

27.5 ± 4.9

21.1 ± 4.8

−6.3 ± 2.5***

20.3 ± 4.6

−7.2 ± 3.1***,†††

Brain

1.5 ± 0.2

1.5 ± 0.2

0.0 ± 0.0

1.5 ± 0.2

0.0 ± 0.0

Inner organs

2.0 ± 0.3

1.9 ± 0.3

−0.1 ± 0.1***

1.9 ± 0.3

−0.1 ± 0.1***

Bone

4.4 ± 0.7

4.5 ± 0.7

0.0 ± 0.1**

4.5 ± 0.7

0.0 ± 0.1

13.0 ± 2.9

13.1 ± 2.7

Residual mass

**, ***p < 0.01, 0.001 vs. month 0,

0.1 ± 0.7

13.3 ± 2.6

0.3 ± 0.9***,†††

†††

p < 0.001 vs. month 6.

RESULTS
The present analysis included 77 women and 32 men (n = 109)
with complete data at baseline and 12 months (Table 1).
Body weight declined by 7.3 ± 0.2 kg (p < 0.001) from baseline
to 6 months and declined by an additional 0.7 ± 0.2 kg (p < 0.001)
from 6 to 12 months, resulting in a total weight loss of 8.0 ± 0.3 kg
(p < 0.001) (Fig. 1). Among the RMR-contributing tissues and
organs, meaningful changes occurred in skeletal muscle from
baseline to 6 months (−1.0 ± 0.7 kg, p < 0.001) with no further
losses from 6 to 12 months (p = 0.83; Table 2). Reductions in
adipose tissue occurred from baseline to 6 months (−6.3 ± 0.2 kg;
p < 0.001) and further from 6 to 12 months (p < 0.001) for a total
loss of 7.2 ± 3.0 kg. No or only minimal changes were observed for
brain, inner organ, bone and residual mass (Table 2).

At baseline, there was no difference between measured and
predicted RMR (1408 ± 18 kcal/d vs. 1437 ± 19 kcal/d). Measured
RMR decreased by 101 ± 12 kcal/d (−7.6%, p < 0.001) from baseline to 6 months, and there was no further decline from 6 to
12 months (p = 0.59; Fig. 1). Predicted RMR was reduced by 60 ±
3 kcal/d (−4.2%, p < 0.001) from baseline to 6 months, with no
further decline from 6 to 12 months (p = 0.58). Per our operational
deﬁnition, the additional 40 ± 11 kcal/d reduction in measured
RMR were attributed to metabolic adaptations.
Individual changes in measured RMR, RMR predicted from
changes in organ and tissues, and metabolic adaptations are
shown in Fig. 2. Following the intervention, 83% of participants
experienced a reduction in RMR. Of the participants who
experienced a reduction in RMR, the reduction in RMR was
International Journal of Obesity (2022) 46:1168 – 1175
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Fig. 2 Individual changes in measured resting metabolic rate, resting metabolic rate predicted from changes in organ and tissues, and
metabolic adpatations. Contribution of tissue losses and gains (gray bars) and metabolic adaptations (white bars) to the individual changes in
resting metabolic rate measured by indirect calorimetry (black diamond) in response to caloric restriction.

Fig. 3 Changes in Resting Metabolic Rate (RMR) based on the
amount of skeletal muscle and adipose tissue loss from baseline
to month 12. Black bars depict changes in RMR measured by
indirect calorimetry, dark gray bars depict changes in RMR predicted
from skeletal muscle mass (top) or adipose tissue (bottom), light
gray bars depict changes in RMR predicted from the other organ
and tissues, and white bars depict metabolic adaptations. All
comparisons are adjusted for age, sex, weight, height, initial body
mass index (kg/m2), and body fat percentage.

between 0 and 100 kcal/d in 27%, between 100 and 200 kcal/d in
33%, between 200 and 300 kcal/d in 21%, and >300 kcal/d in 2%.
In 61%, metabolic adaptations contributed more substantially to
the change in RMR than tissue and organ changes, and 33% of
participants experienced positive metabolic adaptations, i.e., an
increase in RMR despite tissue losses.
Upon examination of the relationship between tissue losses and
the reductions in RMR and metabolic adaptations, there were no
discernible associations between changes in skeletal muscle mass
and measured RMR (p = 0.16) nor between changes in skeletal
muscle mass and metabolic adaptations (p = 0.36) (Supplementary Fig. 1). A signiﬁcant linear relationship was observed between
changes in adipose tissue mass and measured RMR (17 kcal/kg;
p < 0.001) and between changes in adipose tissue mass and
metabolic adaptations (12 kcal/kg; p < 0.001) (Supplementary Fig.
2). After stratifying participants into quartiles based on losses in
skeletal muscle and adipose tissue mass, there was no discernible
difference between changes in measured RMR and the amount of
skeletal muscle lost (Fig. 3). In Q1, where individuals experienced
the greatest loss of skeletal muscle mass (1.6–2.9 kg), skeletal

International Journal of Obesity (2022) 46:1168 – 1175

muscle loss only accounted for 26.7% of the RMR reduction.
Reductions in other organs and tissues accounted for another
67.7%, resulting in a reduction in RMR that was almost completely
(94.4%) accounted for by all tissue losses. As less skeletal muscle
was lost, the proportion of RMR reduction accounted for by total
tissue losses declined (p < 0.001). As a result, the proportion of
metabolic adaptations accounting for the overall reduction in RMR
increased steadily from Q1 (5.6%) to Q4 of skeletal muscle (63.9%),
although this increase failed to achieve statistical signiﬁcance
(p = 0.11).
When dividing participants into quartiles based on adipose
tissue losses, the reduction in measured RMR declined as less
adipose tissue was lost, as did the reduction in predicted RMR
from tissue losses (Fig. 3). In individuals with the greatest loss of
adipose tissue (Q1: 8.7–18.8 kg), adipose tissue loss accounted for
31.3% of RMR reduction and the loss of other tissues accounted
for another 18.3%, resulting in total tissue losses accounting for
49.6% of the reduction in RMR. The proportion of RMR reduction
explained by all tissue and organ losses increased proportionally
from Q2 (57.2%) to Q4 (94.5%). Consequently, metabolic adaptations, which decreased in their contribution to RMR reduction
from Q1 (50.4%) to Q4 (5.5%), were positively associated with
adipose tissue losses (p < 0.001, b = 11.9 kcal/kg adipose tissue).
There were signiﬁcant reductions in metabolic hormones after
12 months, with the exception of IGF-1 (Fig. 4). The largest decline
occurred in leptin, which decreased by 59.9 ± 2.2% (p < 0.001). T3
(−14.3 ± 2.0%) and insulin (−14.3 ± 4.6%) were also signiﬁcantly
reduced (both p < 0.001). Reductions in leptin (r = 0.27, p < 0.01),
T3 (r = 0.19, p < 0.05), and insulin (r = 0.25, p < 0.01) were all
signiﬁcantly correlated with metabolic adaptations (Fig. 4).
DISCUSSION
The present retrospective analysis of data from a large, wellcontrolled randomized trial conﬁrms that RMR is reduced by a
magnitude of ~100 kcal (~7%) in response to weight loss of ~11%
achieved through caloric restriction in healthy normal weight and
overweight individuals. On average, only 60% of the total
reduction in RMR were explained by losses of energy-expending
tissues, while the remaining 40% of RMR reduction can be
attributed to metabolic adaptations. However, there was substantial variability between participants in RMR changes as well as
in the contributions of tissue losses and metabolic adaptations to
RMR changes.
The observed RMR reduction by 7% is similar to previous, albeit
shorter and more aggressive weight loss studies, such as in
individuals who lost 9.6 kg (~10% of initial body weight) and
exhibited a 9% reduction in RMR [36] after 8 weeks on a very-lowenergy diet (500 kcal/day). Similarly, a 10% reduction in RMR was
reported in participants who lost 8.9 kg (~9% of initial body
weight) after consuming 550–660 kcal/day for 4 weeks [37].
Upon analysis of tissue-speciﬁc weight loss in CALERIE, we
observed that the primary components lost during the
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Fig. 4 Reductions in metabolic hormones over the course of 12 months of calorie-restricted weight loss. Reductions in leptin,
trioiodothyronine (T3), insulin, and insulin-like growth factor-1 (IGF-1) (top left) and correlations between leptin (top right), insulin (bottom
left), and T3 (bottom right) with metabolic adaptations. *p < 0.05; **p < 0.01.

intervention were skeletal muscle and adipose tissue, while the
remaining organs and tissues were largely preserved. The selective
loss of these two components aligns with a previous examination
of the speciﬁc composition of FFM loss during weight loss, which
observed no disproportionate loss of high-metabolically active
organs when compared to skeletal muscle [17]. While bone
mineral density can be reduced following weight loss, bone mass
was not lowered in the present study, which could be attributed
to the slow rate of weight loss when compared to more restrictive
weight loss reporting bone loss and the provision of calcium
supplementation [38]. Consequently, we stratiﬁed participants
into quartiles based on skeletal muscle losses, rather than
examining it along with the other components of FFM (e.g., bone,
brain, inner organs) that were largely preserved. We observed that
individuals who lost the greatest amount of skeletal muscle
exhibited a reduction in RMR that was only ~25% explained by
skeletal muscle itself, but almost entirely explained by the
reduction of all energy-expending tissues (95%). As the other
components of FFM were relatively preserved, the other 65% of

the RMR reduction explained by tissues is attributable to the large
losses in adipose tissue. The contribution of all tissue losses to the
reduction observed in RMR became less prominent in Q2–Q4 of
skeletal muscle loss, increasing the contribution of metabolic
adaptations to the reduction in RMR across Q2–Q4 despite
improved skeletal muscle preservation.
Our results differ from other studies reporting that reductions in
RMR were almost entirely explained by reductions in FFM, such as
the 6% reduction in RMR following 3 weeks of a low-energy diet
and 1.9 kg reduction in FFM [39] or the even more substantial FFM
losses (−3.4 kg) occurring after 10-16 weeks of caloric restriction
[14], which resulted in an unaltered RMR when expressed relative
to FFM. However, it is important to note that these studies looked
at overall FFM, rather than the speciﬁc component that is primarily
lost (i.e., skeletal muscle) and its associated expenditure. Aside
from bone, skeletal muscle expends substantially less energy
(~13 kcal/kg/d) than the other organs that make up FFM
(~200–450 kcal/kg/d). Because our approach examined the loss
of each tissue and organ, we were able to calculate the direct
International Journal of Obesity (2022) 46:1168 – 1175

A. Martin et al.

1173
energy footprint associated with the loss of each tissue. When
taking its lower tissue-speciﬁc energy expenditure relative to the
other higher expenditure components of FFM into account, it is
therefore not surprising that skeletal muscle losses did not explain
all RMR reductions.
While tissue changes explained slightly more than half of the
RMR reduction following weight loss (60%), Fig. 2 suggests the
high inter-individual variation in RMR occurred as a result of
metabolic adaptations. RMR reductions secondary to metabolic
adaptations have been frequently observed after weight loss
[19, 29, 30, 40, 41], and are understood as a sign of the
suppression of non-vital processes to decrease energy expenditure, which ultimately attenuates weight loss [42, 43]. The extent
of metabolic adaptations in the present study was quantiﬁed at
~40 kcal/d following 12 months of a 25% caloric deﬁcit. Using the
same method, Müller et al. quantiﬁed metabolic adaptations of
~70 kcal/d in a shorter and more restrictive setting of a 50%
energy deﬁcit over only 7 days [19].
Our analysis further indicated that the extent of metabolic
adaptations in the present study was strongly related to the
amount of adipose tissue lost. This positive association between
adipose loss and metabolic adaptations is in agreement with
previous studies in individuals with obesity undergoing gastric
bypass surgery or an intensive weight loss program [21]. Both sets
of participants lost ~40–50 kg weight, but adipose tissue losses
differed. Yet the extent of metabolic adaptations appeared to be
commensurate to adipose tissue losses. When expressing metabolic adaptations relative to adipose tissue losses, both groups
experienced metabolic adaptations in the same range (201 kcal/
26.5 kg = 7.6 kcal/kg; 419 kcal/47.9 kg = 8.7 kcal/kg) [21] as what
we observed in Q1 of adipose tissue losses (79 kcal/10.9 kg =
7.2 kcal/kg tissue). To further corroborate the presence of
metabolic adaptations, the extent of metabolic adaptations in
our sample was strongly correlated to changes in circulating
concentrations of the key energy-sensing hormones leptin and T3.
While conﬁrming the associative nature of reductions in metabolic
hormones and metabolic adaptations, our data are strengthened
by ﬁndings that exogenous administration of leptin and T3 at least
partially reverse reductions in energy expenditure following
weight loss [44]. However, it remains to be tested whether
metabolic hormone replacement attenuates adaptive reductions
in the metabolic activity of the remaining tissues and organs,
which could make it an interesting strategy to combat the
metabolic adaptations leading to RMR reduction.
Despite multiple literature reports of metabolic adaptations
following weight loss, it is important to note that there is no gold
standard method for its direct measurement. Metabolic adaptations represent the difference between measured and predicted
RMR. To optimize its quantiﬁcation, we utilized DXA data, which
enabled more speciﬁc quantiﬁcation of energy-expending tissues
and organs to improve the prediction of RMR [34]. The equations
and coefﬁcients used in the present study were previously
established and validated in examinations of underweight, normal
weight, and individuals with obesity [33] across adulthood [45], in
several weight-loss settings [32, 35], and for the quantiﬁcation of
metabolic adaptations in non-obese men [19]. While some of
these studies estimated inner organ masses using magnetic
resonance imaging, we remain conﬁdent that this present method
of calculating metabolic adaptations was able to effectively
compare the extent of metabolic adaptations across the
intervention. To test the predictability of our model, we compared
measured and predicted RMR at baseline in a presumed state of
energy balance and found no systematic difference between
measured and predicted RMR (p = 0.27).
While the present analysis describes the contribution of
changes in energy-expending tissues and organs and metabolic
adaptations to the reduction in RMR in a large caloric restriction
trial, it was conducted in non-obese individuals, whose weight loss
International Journal of Obesity (2022) 46:1168 – 1175

requirements are not the same as individuals with obesity.
However, given that changes in non-adipose tissues tend to be
greater in leaner individuals [46], the non-obese study population
allowed us to examine a wider spectrum of body composition
changes and ascertain how their contribution to RMR reductions
during weight loss varies depending on whether they are lost or
preserved. Further, the way in which caloric restriction was
attained was not tightly controlled. However, our analysis focused
on the two additive components of RMR reduction occurring
secondary to weight loss, irrespective of how weight loss was
achieved.
CONCLUSIONS
Our analysis demonstrates that RMR is inevitably reduced after
weight loss in healthy normal weight and overweight individuals
and that this reduction occurs through a combination of the loss
of energy-expending tissues and metabolic adaptations. As
hypothesized, the loss of energy-expending tissues—predominantly skeletal muscle and adipose tissue—contributed to the
reduction in RMR, although on average for only ~60% (60 ± 3
kcal/d), leaving the remaining 40% of the RMR reduction
(40 ± 11 kcal/d) attributable to metabolic adaptations. More
importantly, the contribution of tissue losses and metabolic
adaptations to overall RMR reduction was highly variable
between individuals. Contrary to common belief, there was no
discernible relationship between the loss of skeletal muscle, the
primary lean tissue component that is lost during weight loss, and
reductions in RMR. Conversely, the loss of adipose tissue was
related to reductions in RMR and metabolic adaptations, whereby
metabolic adaptations were greatest in individuals who lost the
most adipose tissue. Given the differential impact of these
components to RMR reduction following weight loss, future
research should examine whether the preservation of the tissues
or their metabolic activity yields differential results toward RMR
reductions and weight maintenance and whether more personalized strategies addressing the speciﬁc cause of the RMR
reduction may help maximize weight loss and prevent weight
regain.

REFERENCES
1. WHO WHO. Obesity and overweight 2020 [updated 1 Apr 2020. https://www.
who.int/news-room/fact-sheets/detail/obesity-and-overweight.
2. Ryan DH, Kahan S. Guideline Recommendations for Obesity Management. Med
Clin North Am. 2018;102:49–63.
3. Ryan DH, Yockey SR. Weight Loss and Improvement in Comorbidity: differences
at 5%, 10%, 15%, and Over. Curr Obes Rep. 2017;6:187–94.
4. Chao AM, Quigley KM, Wadden TA. Dietary interventions for obesity: clinical and
mechanistic ﬁndings. J Clin Investig. 2021;131:1–10.
5. Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, et al. Weightloss outcomes: a systematic review and meta-analysis of weight-loss clinical trials
with a minimum 1-year follow-up. J Am Diet Assoc. 2007;107:1755–67.
6. Redman LM, Heilbronn LK, Martin CK, de Jonge L, Williamson DA, Delany JP, et al.
Metabolic and behavioral compensations in response to caloric restriction:
implications for the maintenance of weight loss. PLoS ONE. 2009;4:e4377.
7. Anastasiou CA, Karfopoulou E, Yannakoulia M. Weight regaining: from statistics
and behaviors to physiology and metabolism. Metabolism. 2015;64:1395–407.
8. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from
altered body weight. N Engl J Med. 1995;332:621–8.
9. Martin CK, Heilbronn LK, de Jonge L, DeLany JP, Volaufova J, Anton SD, et al.
Effect of calorie restriction on resting metabolic rate and spontaneous physical
activity. Obesity (Silver Spring, Md). 2007;15:2964–73.
10. Schwartz A, Doucet E. Relative changes in resting energy expenditure during
weight loss: a systematic review. Obesity Rev: Ofﬁcial J Int Assoc Study Obesity.
2010;11:531–47.
11. Astrup A, Buemann B, Christensen NJ, Madsen J, Gluud C, Bennett P, et al. The
contribution of body composition, substrates, and hormones to the variability in
energy expenditure and substrate utilization in premenopausal women. J Clin
Endocrinol Metab. 1992;74:279–86.

A. Martin et al.

1174
12. Lazzer S, Bedogni G, Lafortuna CL, Marazzi N, Busti C, Galli R, et al. Relationship
between basal metabolic rate, gender, age, and body composition in 8,780 white
obese subjects. Obesity (Silver Spring, Md). 2010;18:71–8.
13. Connolly J, Romano T, Patruno M. Selections from current literature: effects of
dieting and exercise on resting metabolic rate and implications for weight
management. Fam Pract. 1999;16:196–201.
14. Ravussin E, Lillioja S, Anderson TE, Christin L, Bogardus C. Determinants of 24hour energy expenditure in man. Methods and results using a respiratory
chamber. J Clin Investig. 1986;78:1568–78.
15. Goele K, Bosy-Westphal A, Rumcker B, Lagerpusch M, Müller MJ. Inﬂuence of
changes in body composition and adaptive thermogenesis on the difference
between measured and predicted weight loss in obese women. Obesity Facts.
2009;2:105–9.
16. Elia M. Organ and tissue contribution to metabolic rate IN Energy metabolism: tissue determinant and cellular corrolaries. New York, NY: Raven Press;
1992.
17. Gallagher D, Kelley DE, Thornton J, Boxt L, Pi-Sunyer X, Lipkin E, et al. Changes in
skeletal muscle and organ size after a weight-loss intervention in overweight and
obese type 2 diabetic patients. Am J Clin Nutr. 2017;105:78–84.
18. Bosy-Westphal A, Braun W, Schautz B, Müller MJ. Issues in characterizing resting
energy expenditure in obesity and after weight loss. Front Physiol. 2013;4:47.
19. Müller MJ, Enderle J, Pourhassan M, Braun W, Eggeling B, Lagerpusch M, et al.
Metabolic adaptation to caloric restriction and subsequent refeeding: the Minnesota Starvation Experiment revisited. Am J Clin Nutr. 2015;102:807–19.
20. Müller MJ, Bosy-Westphal A.Adaptive thermogenesis with weight loss in humans.
Obesity (Silver Spring. Md).2013;21:218–28.
21. Knuth ND, Johannsen DL, Tamboli RA, Marks-Shulman PA, Huizenga R, Chen KY.
et al.Metabolic adaptation following massive weight loss is related to the degree
of energy imbalance and changes in circulating leptin.Obesity (Silver Spring.
Md).2014;22:2563–9.
22. Koehler K, Williams NI, Mallinson RJ, Southmayd EA, Allaway HC, De Souza MJ.
Low resting metabolic rate in exercise-associated amenorrhea is not due to a
reduced proportion of highly active metabolic tissue compartments. Am J Physiol
Endocrinol Metab. 2016;311:E480–7.
23. Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol
Rev. 2014;94:355–82.
24. Kosmiski L, Schmiege SJ, Mascolo M, Gaudiani J, Mehler PS. Chronic starvation
secondary to anorexia nervosa is associated with an adaptive suppression of
resting energy expenditure. J Clin Endocrinol Metab. 2014;99:908–14.
25. Rochon J, Bales CW, Ravussin E, Redman LM, Holloszy JO, Racette SB, et al. Design
and conduct of the CALERIE study: comprehensive assessment of the long-term
effects of reducing intake of energy. J Gerontol Series A, Biol Sci Med Sci.
2011;66:97–108.
26. Redman LM, Smith SR, Burton JH, Martin CK, Il’yasova D, Ravussin E. Metabolic
Slowing and Reduced Oxidative Damage with Sustained Caloric Restriction
Support the Rate of Living and Oxidative Damage Theories of Aging. Cell Metab.
2018;27:805–15. e4
27. Rickman AD, Williamson DA, Martin CK, Gilhooly CH, Stein RI, Bales CW, et al. The
CALERIE Study: design and methods of an innovative 25% caloric restriction
intervention. Contemporary Clin Trials. 2011;32:874–81.
28. CALERIE. Database Submission Form | CALERIE: CALERIE; 2020. https://calerie.
duke.edu/database-submission-form.
29. Fothergill E, Guo J, Howard L, Kerns JC, Knuth ND, Brychta R, et al. Persistent
metabolic adaptation 6 years after “The Biggest Loser” competition. Obesity
(Silver Spring, Md). 2016;24:1612–9.
30. Tremblay A, Chaput JP. Adaptive reduction in thermogenesis and resistance to
lose fat in obese men. Br J Nutr. 2009;102:488–92.
31. Das SK, Roberts SB, Bhapkar MV, Villareal DT, Fontana L, Martin CK, et al. Bodycomposition changes in the Comprehensive Assessment of Long-term Effects of
Reducing Intake of Energy (CALERIE)-2 study: a 2-y randomized controlled trial of
calorie restriction in nonobese humans. Am J Clin Nutr. 2017;105:913–27.
32. Bosy-Westphal A, Kossel E, Goele K, Later W, Hitze B, Settler U, et al. Contribution
of individual organ mass loss to weight loss-associated decline in resting energy
expenditure. Am J Clin Nutr. 2009;90:993–1001.
33. Bosy-Westphal A, Reinecke U, Schlorke T, Illner K, Kutzner D, Heller M, et al. Effect
of organ and tissue masses on resting energy expenditure in underweight,
normal weight and obese adults. Int J Obes Relat Metab Disord. 2004;28:72–9.
34. Hayes M, Chustek M, Wang Z, Gallagher D, Heshka S, Spungen A, et al. DXA:
potential for creating a metabolic map of organ-tissue resting energy expenditure components. Obes Res. 2002;10:969–77.
35. Pourhassan M, Bosy-Westphal A, Schautz B, Braun W, Gluer CC, Müller MJ. Impact
of body composition during weight change on resting energy expenditure and
homeostasis model assessment index in overweight nonsmoking adults. Am J
Clin Nutr. 2014;99:779–91.

36. Camps SG, Verhoef SP, Westerterp KR. Weight loss, weight maintenance, and
adaptive thermogenesis. Am J Clin Nutr. 2013;97:990–4.
37. Coutinho SR, With E, Rehfeld JF, Kulseng B, Truby H, Martins C. The impact of rate
of weight loss on body composition and compensatory mechanisms during
weight reduction: a randomized control trial. Clin Nutr. 2018;37:1154–62.
38. Hunter GR, Plaisance EP, Fisher G. Weight loss and bone mineral density. Curr
Opin Endocrinol Diabetes Obes. 2014;21:358–62.
39. Menozzi R, Bondi M, Baldini A, Venneri MG, Velardo A, Del Rio G. Resting
metabolic rate, fat-free mass and catecholamine excretion during weight loss in
female obese patients. Br J Nutr. 2000;84:515–20.
40. Heilbronn LK, de Jonge L, Frisard MI, DeLany JP, Larson-Meyer DE, Rood J, et al.
Effect of 6-month calorie restriction on biomarkers of longevity, metabolic
adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. Jama. 2006;295:1539–48.
41. Johannsen DL, Knuth ND, Huizenga R, Rood JC, Ravussin E, Hall KD. Metabolic
slowing with massive weight loss despite preservation of fat-free mass. J Clin
Endocrinol Metab. 2012;97:2489–96.
42. Byrne NM, Wood RE, Schutz Y, Hills AP. Does metabolic compensation explain the
majority of less-than-expected weight loss in obese adults during a short-term
severe diet and exercise intervention? Int J Obesity. 2012;36:1472–8.
43. Wade GN, Schneider JE, Li HY. Control of fertility by metabolic cues. Am J Physiol.
1996;270:E1–19.
44. Rosenbaum M, Goldsmith RL, Haddad F, Baldwin KM, Smiley R, Gallagher D, et al.
Triiodothyronine and leptin repletion in humans similarly reverse weight-lossinduced changes in skeletal muscle. Am J Physiol Endocrinol Metab. 2018;315:
E771–9.
45. Wang Z, Ying Z, Bosy-Westphal A, Zhang J, Schautz B, Later W, et al. Speciﬁc
metabolic rates of major organs and tissues across adulthood: evaluation by
mechanistic model of resting energy expenditure. Am J Clin Nutr.
2010;92:1369–77.
46. Forbes GB. Body fat content inﬂuences the body composition response to
nutrition and exercise. Ann N Y Acad Sci. 2000;904:359–65.

ACKNOWLEDGEMENTS
This research was funded internally through the Technical University of Munich and
the University of Nebraska-Lincoln, including a Ronald E. McNair scholarship
awarded to DF.

AUTHOR CONTRIBUTIONS
The analysis was conceptualized by AM, DF, and KK; methodological considerations
were implemented by AM, DF, CM, and KK; the formal data analysis was performed
by CM and KK; data curation and supervision were conducted by DF and KK; the
original paper was prepared by AM under the supervision of HH; preparation and
presentation of the published work by AM and DF; oversight and leadership
responsibility for the research activity by HH and KK; funding was acquired by DF
and KK.

FUNDING
Open Access funding enabled and organized by Projekt DEAL.

COMPETING INTERESTS
The authors declare no competing interests.

ADDITIONAL INFORMATION
Supplementary information The online version contains supplementary material
available at https://doi.org/10.1038/s41366-022-01090-7.
Correspondence and requests for materials should be addressed to Karsten Koehler.
Reprints and permission information is available at http://www.nature.com/
reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims
in published maps and institutional afﬁliations.

International Journal of Obesity (2022) 46:1168 – 1175

A. Martin et al.

1175
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.

© The Author(s) 2022

International Journal of Obesity (2022) 46:1168 – 1175

